We are delighted to announce that Accord Healthcare was the most recognised company at the Global Generics & Biosimilar Awards 2018, having won awards for: Company of the Year and Biosimilar Initiative of the Year.
Read MorePelgraz - a pegylated G-CSF Biosimilar, is latest addition to Accord Healthcare's established portfolio of over 30 oncology treatments across Europe
Read MoreOver the past two weeks, we have continued to further our expansion in Europe with the opening of a new office in Basel, Switzerland and further expansion of operations in Austria.
Read MoreThe 'India Meets Britain Tracker 2018', released annually by Grant Thornton in collaboration with the Confederation of Indian Industry awards the fastest UK based companies of Indian origin.
Read MoreAs East Area Director for the vast CEE market, Paweł Mazur explains how Accord Healthcare Poland
Read MoreOur Fawdon factory in Newcastle recently welcomed Cllr Ged Bell, from Newcastle City Council and Keith Daniels, Site Head was able to bring him up to date with the latest news from the site.
Read MoreGrowth in the Time of Brexit: Pharm Exec speaks with our executive VP, Europe & EMENA, James Burt, about the company’s vision for the UK and Europe post-Brexit, the challenges of retaining the company’s culture amid major growth, and the current landscape for generic medicines.
Read MoreAs Member of Medicines for Europe, we are happy to support the “Access To Medicines: Better Care for More Patients” campaign.
Read More
